News | News By Subject | News by Disease News By Date | Search News

Inflammatory diseases (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
AstraZeneca PLC (AZN) Passes Off Another Amgen (AMGN)-Partnered Drug Candidate in $1.5 Billion Deal With Allergan (AGN)     10/4/2016
FDA Clears Amgen (AMGN) Copy of AbbVie (ABBV)'s Blockbuster Humira     9/26/2016
Amgen (AMGN) Cringes as FDA Approves Novartis AG (NVS)'s Anti-Inflammatory Drug Erelzi     8/31/2016
Gilead (GILD) Invests Up to $2 Billion in Galapagos (GLPG.BR)’ Anti-inflammatory Drug     12/18/2015
Roche (RHHBY), Upsher-Smith Laboratories Partner Up to Develop Inflammatory Disease Drug     12/1/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Novartis AG (NVS)'s AIN457 Meets Primary Endpoint In Two Late Stage Studies     10/23/2014
Telormedix' Vesimune Successfully Completes Phase 2 For Carcinoma In Situ Of The Bladder     5/16/2014
AstraZeneca PLC (AZN) Chases Demon Disease Cure, Potential To Be A Blockbuster Drug     2/17/2014
Novartis Pharma AG (NVS) (JOBS) Obtains EU Positive Opinion For New Biologic Drug     7/29/2009
Regeneron Pharmaceuticals, Inc. (REGN) (JOBS) Receives European Medicines Agency Positive Opinion for Marketing Authorization of Rilonacept for the Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)     7/24/2009
US Approves Novartis AG (JOBS) Auto-Inflammatory Drug     6/19/2009
Hollis-Eden Pharmaceuticals Inc. (HEPH) Provides Update on Clinical Development Programs; Announces First Quarter 2008 Financial Results     5/13/2008

News from Around the Web
Poor Sleep Health Could Contribute To Inflammatory Disease, UCLA Study     7/6/2016
Curcumin May Help Overcome Drug-Resistant Tuberculosis, University of Colorado Study     3/25/2016
Universite Laval Researchers Identify Molecule With Anti-Inflammatory Properties In Maple Syrup     12/23/2015
Worms And Germs Lead To Better Immune Function, Duke University Medical Center Study     4/10/2015
Disruption Of Circadian Rhythms May Contribute To Inflammatory Disease, Rush University Medical Center Study     5/22/2014
Bone Loss Seen Early in Inflammatory Disorders, VU University Medical Center Study     8/18/2010
Disease Genes That Followed The Silk Road Identified, University of Manchester Study     7/20/2010
New Drug Target For Inflammatory Disease Discovered by University of California, Davis (UCD) Researchers     9/25/2008
Key Protein Molecule Linked To Diverse Human Chronic Inflammatory Diseases, Virginia Tech Study     9/17/2008
Caspase-12: McGill University Researcher Finds New Defense Mechanism Against Intestinal Inflammation     3/13/2008
University of Central Florida Researchers Discover A New Protein Family Implicated In Inflammatory Diseases     3/11/2008
Biomarkers for Inflammatory Disease     12/6/2007
New Insights into Inflammation in Osteoarthritis     10/29/2007
Potential New Way of Treating Inflammatory Diseases Identified     9/14/2007
Muscle Cream Caused NYC Teen's Death     6/11/2007

Press Releases
Atlantic Healthcare Confirms Alicaforsen Targets TLR-9, Providing A Second Mechanism Of Action To Treat New And Existing Inflammatory Indications     2/28/2017
X-Chem Expands Collaboration With Janssen Biotech (JNJ) In Inflammatory Diseases     2/15/2017
CytoDyn (CYDY)’s Two-Year Update On Its PRO 140 Monotherapy Study In HIV Accepted At CROI 2017     11/16/2016
Momenta (MNTA) And Mylan (MYL) Initiate Phase I Clinical Trial For M834, A Proposed Biosimilar Of ORENCIA (Abatacept)     11/2/2016
Dermira (DERM) Presents Data From DRM01 Phase IIb Clinical Program At Annual Meeting For Dermatologists     10/21/2016
GlycoMimetics, Inc. (GLYC) Announces Publication Of Preclinical Data Showing Drug Candidate GMI-1271 Reduces Inflammatory Responses After Heart Attack     8/16/2016
Theravance Biopharma (TBPH) Reports Positive Results From Phase 1 Clinical Trial Of TD-1473, A GI-Targeted Pan-Janus Kinase (JAK) Inhibitor     6/9/2016
TxCell Presents A Series Of New Scientific Data At The ISCT 2016 Annual Meeting     5/26/2016
Galapagos (GLPG.BR) And MorphoSys AG Initiate Phase I Study In Joint Antibody Program MOR106     4/7/2016
X-Chem Announces License With Janssen Biotech Inc. (JNJ) For Protein:Protein Inhibitor Program In Inflammatory Disease     3/30/2016
Fibrocell Science, Inc. Highlights Recent Pipeline Accomplishments     1/27/2016
CorMedix (CRMD) To Present At Biotech Showcase 2016     1/6/2016
U.S. Patents Issued To Akaal Pharma On S1P1 Receptor Modulators Useful For The Treatment Of Autoimmune And Inflammatory Diseases     12/11/2015
Eiger Biopharma Announces License Agreement With Nippon Kayaku Co., Ltd. To Develop Bestatin (ubenimex) For Inflammatory Diseases Involving LTB4     11/9/2015
AbbVie (ABBV)'s Leadership And Innovation In Immunology Showcased At The American College of Rheumatology Annual Meeting With More Than 40 Abstracts On HUMIRA (adalimumab) And Investigational Medicines Across Multiple Inflammatory Diseases     11/3/2015